DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bidard FC, Callens C, Dalenc F. et al.
Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.
J Clin Oncol 2020;
38 (no. 15_suppl): 1010
doi:10.1200/JCO.2020.38.15_suppl.1010
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.